Home » Topics » Regulatory » Patents

Patents
RSS

GNT Biotech & Medicals presents new HDAC inhibitors

Nov. 18, 2021

Gasherbrum Bio patents GLP-1 receptor agonists

Nov. 18, 2021

Medshine Discovery discloses new MAPK inhibitors

Nov. 18, 2021

Accutar Biotechnology describes new compounds for cancer

Nov. 17, 2021

Shenzhen Jingtai Technology discloses new Ret inhibitors

Nov. 17, 2021

IMMvention Therapeutix synthesizes NLRP3 inflammasome inhibitors

Nov. 17, 2021

Chinese researchers divulge GTPase KRAS mutant inhibitors

Nov. 17, 2021

Assembly Biosciences patents new compounds for HBV

Nov. 17, 2021

C4X Discovery Holdings patents NFE2L2 activators

Nov. 16, 2021

Plexxikon identifies new CD73 inhibitors

Nov. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...